Navigation Links
Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
Date:9/4/2007

PRESTON, England, Sept. 4 /PRNewswire-FirstCall/ -- Six hospitals in the north of England are implementing a Varian Medical Systems (NYSE: VAR) software system that enables them to function as one clinical network. The rollout of ARIA(TM) for Medical Oncology at hospitals in Lancashire and Cumbria is expected to improve patient care and departmental efficiency by fully integrating the prescribing, preparation, dispensing and administration of drugs for treating cancer.

The network will include oncology centers at the Royal Preston Hospital, Royal Blackburn Hospital, Burnley General Hospital, Blackpool Victoria Hospital, Royal Lancs Infirmary and Furness General Hospital will effectively have a single integrated computer network for chemotherapy prescribing and patient records.

Dr Gerry Skailes, the project's clinical director of oncology, says, "This will allow a seamless transition around the network and will enable patients to travel from one of our hospitals to another, as they tend to do if they are having both chemotherapy and radiotherapy. ARIA was selected because it ideally fitted our specifications and it is a well-established and trusted system.

"The result will be a more streamlined service which will enable us to provide better care for our patients while increasing our awareness of the treatments we are providing. It will make it a lot more convenient for all concerned."

Steve Laws, Varian's medical oncology sales manager, says, "ARIA for Medical Oncology provides cancer treatment facilities with software that combines and manages information including scheduling, prescribing and clinical information for both radiation therapy and chemotherapy within a single comprehensive electronic medical record for each patient."

Varian's medical oncology solution is already in place in several UK hospitals, including in London (St Barts), Norwich, Stoke, Truro and Romford, and is now being implemented across a number of other cancer networks.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068, neil.madle@varian.com

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,400 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. In Europe, the company operates manufacturing and engineering centers in Baden (Switzerland), Crawley (England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug, Switzerland. For more information, visit http://www.varian.com/.

Forward Looking Statements

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Midwest shines among best hospitals in U.S.
2. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
3. Digitizing hospitals with the right tools
4. GE Healthcare launches new medical scanner, places another in hospitals
5. TeraMedica offers system integration tool for hospitals
6. TDS Helps Florida Hospitals Implement High-Speed VPN
7. Avoid siRNA Design Altogether!
8. A (modern) Tale of Two Cities: Milwaukee and Madison inch together
9. Old bell system merging back together, but its not the same
10. The year of working together (really!)
11. Education conference to draw together games researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ...   - Lifitegrast has the potential to be the ... signs and symptoms of dry eye disease in adults ... product approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") ... products in China , today announced ... received on February 4, 2016 a preliminary non-binding proposal ... of PKU V-Ming ( Shanghai ) Investment ... Development ( Shenzhen ) Fund Management Co., ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
Breaking Biology News(10 mins):